Blacklock's Reporter

A federal panel yesterday endorsed national pharmacare in principle but did not explain what kind of program should be introduced or when, or how Parliament would pay for it. The report echoed earlier findings of a Commons committee and federal drug price agency: “No, we are not doing a very good job.”